Company Overview and News

1
Vishay Optoelectronics to Exhibit Latest Light to Digital and Analog Output Sensors at Sensors Expo & Conference 2018

2018-06-21 globenewswire
MALVERN, Pa., June 21, 2018 (GLOBE NEWSWIRE) -- The Optoelectronics group of Vishay Intertechnology, Inc. (NYSE:VSH) today announced its technology lineup for Sensors Expo & Conference 2018, taking place June 26-28 at the McEnery Convention Center in San Jose, California. In booth 435, Vishay will exhibit its latest light to digital and analog output sensor technologies, including infrared (IR), ambient, proximity, ultraviolet (UV), and RGBW light sensors for consumer, industrial, healthcare, security, and wearable applications.
VSH

3
SAIC Looks Promising on Deal Wins & Higher Federal Budget

2018-06-20 zacks
On Jun 20, Science Applications International Corp. (SAIC - Free Report) was upgraded to Zacks Rank #1 (Strong Buy). The upgrade reflects the company’s high-value contract wins and positive earnings estimate revisions. Notably, the Zacks Consensus Estimate for fiscal 2019 earnings increased approximately 4% to $4.46 per share over the last 30 days. Similarly, for fiscal 2020, the consensus estimate increased 7.
MRCY VSH SAIC SABR

114
3 Internet of Things Stocks to Buy Right Now

2018-06-19 investorplace
Semiconductor stocks have been the subject of unpredictable volatility so far this year, but the underlying business of this industry is growing—and should continue that trend in 2018 and beyond. Throughout the chip-making space, companies have successfully adapted to the changing needs of the consumer, including an increased demand for small, high-powered chips that enable “Internet of Things” (IoT) devices.
CY AMZN CREE VSH

37
3 "Internet of Things" Stocks to Buy Right Now

2018-06-18 zacks
Semiconductor stocks have been the subject of unpredictable volatility so far this year, but the underlying business of this industry is growing—and should continue that trend in 2018 and beyond. Throughout the chip-making space, companies have successfully adapted to the changing needs of the consumer, including an increased demand for small, high-powered chips that enable “Internet of Things” (IoT) devices.
HD CY CREE VSH

1
New Vishay Intertechnology Series of Direct Water-Cooled Wirewound Resistors Saves Space and Increases Reliability

2018-06-18 globenewswire
MALVERN, Pa., June 18, 2018 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE:VSH) today introduced a new series of direct water-cooled wirewound resistors that offers ultrahigh power dissipation to 9000 W with almost no external radiation. Available in six compact sizes ranging from 38 mm by 178 mm to 38 mm by 410 mm, Vishay MCB DCRF series devices are designed to save space and increase reliability over standard wirewound resistors.
VSH

197
Looking Behind the Scenes in Semiconductors

2018-06-14 zacks
The semiconductor industry has been red hot this year, up 16.5% as a whole versus 4% for the S&P 500. Top industry players like Micron Technology (MU - Free Report) and Nvidia (NVDA - Free Report) have gotten the lion’s share of the attention from investors – and rightfully so as they have performed even better than the industry.
HD CREE MU VSH CSX NVDA 8035 TOELF YY TOELY

1
Vishay Intertechnology Closes Offering of $600 Million of 2.25% Convertible Senior Notes

2018-06-13 globenewswire
MALVERN, Pa., June 13, 2018 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE:VSH) today announced the closing of its offering of $600 million aggregate principal amount of 2.25% convertible senior notes due 2025. The notes were offered and sold only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
VSH

1
VSH / Vishay Intertechnology, Inc. CURRENT REPORT (Current Report)

2018-06-13 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
VSH

110
Strength Seen in Vishay Intertechnology (VSH): Stock Soars 13.3%

2018-06-08 zacks
Vishay Intertechnology, Inc. (VSH - Free Report) was a big mover last session, as the company saw its shares rise more than 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $20.25 to $21.80 in the past one-month time frame. The company has not seen any estimate revisions in the past month, while its Zacks Consensus Estimate has moved higher over the same time frame, suggesting that more solid trading could be ahead for Vishay Intertechnology.
BRQS CREE MU VSH LB

2
VSH / Vishay Intertechnology, Inc. VISHAY INTERTECHNOLOGY, INC. 8-K (Current Report)

2018-06-08 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
VSH

1
Vishay Intertechnology Prices Offering of $600 Million of 2.25% Convertible Senior Notes

2018-06-08 globenewswire
MALVERN, Pa., June 08, 2018 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE:VSH) today announced the pricing of its offering of $600 million aggregate principal amount of 2.25% convertible senior notes due 2025 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The base size of the offering was increased from the previously announced $525 million in aggregate principal amount to $600 million, and there will be no option for the initial purchasers to purchase additional notes.
VSH DTK

1
VSH / Vishay Intertechnology, Inc. VISHAY INTERTECHNOLOGY, INC. 8-K (Current Report)

2018-06-06 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
VSH

1
Vishay Intertechnology Announces Proposed Offering of $525 Million of Convertible Senior Notes

2018-06-06 globenewswire
MALVERN, Pa., June 06, 2018 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE:VSH) today announced its intention to commence an offering, subject to market conditions and other factors, of $525 million aggregate principal amount of convertible senior notes due 2025. The notes are to be offered and sold only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
VSH

1
Vishay Intertechnology to Showcase Leading Passive Components and Custom Substrates at IMS2018

2018-06-05 globenewswire
MALVERN, Pa., June 05, 2018 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE:VSH) today announced its technology lineup for the 2018 IEEE MTT International Microwave Symposium (IMS2018), being held June 10-15 at the Pennsylvania Convention Center in Philadelphia, Pennsylvania, in booth 1412. At the conference and exhibition, the company will be highlighting its latest industry-leading high frequency multilayer ceramic chip capacitors (MLCCs); specialty and RF thin and thick film resistors; wire bondable RF capacitors and inductors; and custom substrates.
VSH

1
Vishay’s New High Current Planar Choke Inductor Delivers Same Performance as Wirewounds in Fraction of Space

2018-06-04 globenewswire
MALVERN, Pa., June 04, 2018 (GLOBE NEWSWIRE) -- A new high current planar choke inductor that offers the same performance as wirewound devices in a fraction of the space was announced today by Vishay Intertechnology, Inc. (NYSE:VSH). The new IPLA 32 measures just 31 mm by 43 mm by 22.2 mm but is rated for currents up to 110 A, allowing high power density DC/DC converters to occupy a significantly smaller footprint.
VSH

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to VSH / Vishay Intertechnology, Inc. on message board site Silicon Investor.

Vishay Intertechnology VitaminShoppe.com, Inc. (VSHP)
Vishay Intertechnology Vishay Intertechnology
CUSIP: 928298108